Analysis of intercellular lipids in the stratum corneum of patients with capecitabine-induced hand-foot syndrome: comparison with the stratum corneum of healthy individuals.
Saved in:
| Title: | Analysis of intercellular lipids in the stratum corneum of patients with capecitabine-induced hand-foot syndrome: comparison with the stratum corneum of healthy individuals. |
|---|---|
| Authors: | Uchino T; Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan. uchinot@u-shizuoka-ken.ac.jp.; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan. uchinot@u-shizuoka-ken.ac.jp.; Laboratory of Clinical Pharmacokinetics, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan. uchinot@u-shizuoka-ken.ac.jp., Nakajo M; Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Department of Pharmacy, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan., Hatta I; Department of Research, Nagoya Industrial Science Research Institute, 1-13 Yotsuyadori, Chikusa-ku, Nagoya, 464-0819, Japan., Suzuki I; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan., Okada M; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan., Terada R; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan., Miyazaki Y; Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Laboratory of Clinical Pharmacokinetics, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan., Osawa M; Department of Pharmacy, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan., Taku K; Department of Oncology, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan., Yokoyama T; Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Laboratory of Clinical Pharmacokinetics, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan., Tsuji D; Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Laboratory of Clinical Pharmacokinetics, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan., Kagawa Y; Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Laboratory of Clinical Pharmacokinetics, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2026 Jan 19; Vol. 96 (1), pp. 8. Date of Electronic Publication: 2026 Jan 19. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41553537 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Analysis of intercellular lipids in the stratum corneum of patients with capecitabine-induced hand-foot syndrome: comparison with the stratum corneum of healthy individuals. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Uchino+T%22">Uchino T</searchLink>; Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan. uchinot@u-shizuoka-ken.ac.jp.; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan. uchinot@u-shizuoka-ken.ac.jp.; Laboratory of Clinical Pharmacokinetics, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan. uchinot@u-shizuoka-ken.ac.jp.<br /><searchLink fieldCode="AU" term="%22Nakajo+M%22">Nakajo M</searchLink>; Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Department of Pharmacy, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan.<br /><searchLink fieldCode="AU" term="%22Hatta+I%22">Hatta I</searchLink>; Department of Research, Nagoya Industrial Science Research Institute, 1-13 Yotsuyadori, Chikusa-ku, Nagoya, 464-0819, Japan.<br /><searchLink fieldCode="AU" term="%22Suzuki+I%22">Suzuki I</searchLink>; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.<br /><searchLink fieldCode="AU" term="%22Okada+M%22">Okada M</searchLink>; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.<br /><searchLink fieldCode="AU" term="%22Terada+R%22">Terada R</searchLink>; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.<br /><searchLink fieldCode="AU" term="%22Miyazaki+Y%22">Miyazaki Y</searchLink>; Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Laboratory of Clinical Pharmacokinetics, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan.<br /><searchLink fieldCode="AU" term="%22Osawa+M%22">Osawa M</searchLink>; Department of Pharmacy, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan.<br /><searchLink fieldCode="AU" term="%22Taku+K%22">Taku K</searchLink>; Department of Oncology, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan.<br /><searchLink fieldCode="AU" term="%22Yokoyama+T%22">Yokoyama T</searchLink>; Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Laboratory of Clinical Pharmacokinetics, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan.<br /><searchLink fieldCode="AU" term="%22Tsuji+D%22">Tsuji D</searchLink>; Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Laboratory of Clinical Pharmacokinetics, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan.<br /><searchLink fieldCode="AU" term="%22Kagawa+Y%22">Kagawa Y</searchLink>; Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.; Laboratory of Clinical Pharmacokinetics, Shizuoka General Hospital, 4-27-1 Kita-Ando, Aoi-ku, Shizuoka, 420-8527, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227806519%22">Cancer chemotherapy and pharmacology</searchLink> [Cancer Chemother Pharmacol] 2026 Jan 19; Vol. 96 (1), pp. 8. <i>Date of Electronic Publication: </i>2026 Jan 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Comparative Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7806519 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0843 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203445704%22">03445704 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Chemother Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41553537 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00280-025-04842-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 8 Titles: – TitleFull: Analysis of intercellular lipids in the stratum corneum of patients with capecitabine-induced hand-foot syndrome: comparison with the stratum corneum of healthy individuals. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Uchino T – PersonEntity: Name: NameFull: Nakajo M – PersonEntity: Name: NameFull: Hatta I – PersonEntity: Name: NameFull: Suzuki I – PersonEntity: Name: NameFull: Okada M – PersonEntity: Name: NameFull: Terada R – PersonEntity: Name: NameFull: Miyazaki Y – PersonEntity: Name: NameFull: Osawa M – PersonEntity: Name: NameFull: Taku K – PersonEntity: Name: NameFull: Yokoyama T – PersonEntity: Name: NameFull: Tsuji D – PersonEntity: Name: NameFull: Kagawa Y IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 01 Text: 2026 Jan 19 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1432-0843 Numbering: – Type: volume Value: 96 – Type: issue Value: 1 Titles: – TitleFull: Cancer chemotherapy and pharmacology Type: main |
| ResultId | 1 |
